MYC and cancer: Genes in the two identified prognostic multigene signatures added a new pediatric cancer type, neuroblastoma, to the impacts of the cancer prognostic ESC-like signature showing preferential high-expression of MYC targets combined with low-expression of Polycomb-regulated genes [7].